Pharvaris NV Target Price

See Pharvaris NV's analyst price targets ($60) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$31.41

Average Target Price

$60.14

91.5% upside

14 analysts in the last 4 months

High: $79 | Low: $40

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-06	UBS	$60	91% upside
2026-09-14	Cantor FitzgeraldSteven Seedhouse	$65	106.9% upside
2026-09-10	GuggenheimDebjit Chattopadhyay	$44	40.1% upside
2026-09-09	RBC CapitalNevin Varghese	$62	97.4% upside
2026-09-09	Rosenblatt Securities	$60	91% upside
2026-09-09	Morgan Stanley	$62	97.4% upside
2026-09-09	UBS	$79	151.5% upside
2026-09-09	Wells FargoYanan Zhu	$65	106.9% upside
2026-09-09	Wedbush	$50	59.2% upside
2026-09-09	Leerink Partners	$65	106.9% upside
2026-09-08	Oppenheimer	$75	138.8% upside
2026-08-14	New Street	$60	91% upside
2026-08-13	Guggenheim	$40	27.3% upside
2026-07-15	Wells FargoYanan Zhu	$55	75.1% upside
2026-06-25	Morgan StanleyMaxwell Skor	$46	46.5% upside
2026-05-13	UBS	$74	135.6% upside
2026-04-08	Wolfe Research	$42	33.7% upside
2026-03-09	RBC Capital	$52	65.6% upside
2025-12-04	Oppenheimer	$50	59.2% upside
2025-12-04	GuggenheimDebjit Chattopadhyay	$39	24.2% upside
2025-12-04	Morgan StanleyMaxwell Skor	$41	30.5% upside
2025-12-03	Leerink Partners	$38	21% upside
2025-10-15	H.C. Wainwright	$60	91% upside
2024-10-14	OppenheimerJustin Kim	$42	33.7% upside
2024-04-11	JMP SecuritiesJonathan Wolleben	$50	59.2% upside
2023-09-25	WedbushLaura Chico	$27	14% downside
2023-01-11	JMP Securities	$23	26.8% downside
2022-12-09	JMP Securities	$22	30% downside

Pharvaris NV (PHVS) FAQ

As of the most recent data, PHVS shows a target price of $60. Scroll down for historical charts and peer comparison views.

If Pharvaris NV moved to the average analyst target of $60, shares would be roughly 91.5% higher than $31.41. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Pharvaris NV's earnings trajectory.

Besides this target price page, Stockcircle has Pharvaris NV's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $60) with ownership activity and broader fundamentals.

Pharvaris NV's target price is $60; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.